Cargando…

Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants

The heparin polysaccharide nanoparticles block the interaction between heparan sulfate/S protein and inhibit the infection of both wild-type SARS-CoV-2 pseudovirus and the mutated strains through pulmonary delivery. [Figure: see text]

Detalles Bibliográficos
Autores principales:	Tu, Bin, Wang, Huiyuan, An, Xinran, Qu, Jingkun, Li, Qianqian, Gao, Yanrong, Shi, Mingjie, Qiu, Hong, Huang, Yongzhuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830937/ https://www.ncbi.nlm.nih.gov/pubmed/35169535 http://dx.doi.org/10.1016/j.apsb.2022.01.019

Ejemplares similares

Localized delivery of nanomedicine and antibodies for combating COVID-19
por: Tu, Bin, et al.
Publicado: (2023)

Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles
por: Wu, Canhao, et al.
Publicado: (2022)

Cell membrane-derived biomimetic nanodecoys for viruses
por: Liu, Xuan, et al.
Publicado: (2020)

Author correction to “Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles” [Acta Pharmaceutica Sinica B 12 (2022) 1523–1533]
por: Wu, Canhao, et al.
Publicado: (2023)

Cell-Mimicking Nanodecoys Neutralize SARS-CoV-2 and Mitigate Lung Injury in a Nonhuman Primate Model of COVID-19
por: Li, Zhenhua, et al.
Publicado: (2021)

Lipid Metabolism Regulation Based on Nanotechnology for Enhancement of Tumor Immunity
por: Tu, Bin, et al.
Publicado: (2022)

Brain-Targeted Biomimetic Nanodecoys with Neuroprotective Effects for Precise Therapy of Parkinson’s Disease
por: Liu, Yao, et al.
Publicado: (2022)

Nanodecoys: A Quintessential Candidate to Augment Theranostic Applications for a Plethora of Diseases
por: Chatterjee, Sampreeti, et al.
Publicado: (2022)

Cytokine-scavenging nanodecoys reconstruct osteoclast/osteoblast balance toward the treatment of postmenopausal osteoporosis
por: Zhou, Yang, et al.
Publicado: (2021)

Inhalation of Low Molecular Weight Heparins as Prophylaxis against SARS-CoV-2
por: Eder, Julia, et al.
Publicado: (2022)

Sulfated liposome-based artificial cell membrane glycocalyx nanodecoys for coronavirus inactivation by membrane fusion
por: Li, Xu, et al.
Publicado: (2023)

Heparin-Regulated Prodrug-Type Macromolecular Theranostic Systems for Cancer Therapy
por: Wang, Huiyuan, et al.
Publicado: (2017)

Heparin and related polysaccharides : structure and activities
Publicado: (1989)

Editorial: Heparin and Related Polysaccharides
por: Gray, Elaine, et al.
Publicado: (2020)

Erythrocyte membrane with CLIPPKF as biomimetic nanodecoy traps merozoites and attaches to infected red blood cells to prevent Plasmodium infection
por: He, Zhouqing, et al.
Publicado: (2023)

Macrophage targeted iron oxide nanodecoys augment innate immunological and drug killings for more effective Mycobacterium Tuberculosis clearance
por: Shen, Ling, et al.
Publicado: (2023)

Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody
por: Li, Cheng, et al.
Publicado: (2022)

Purification and characterisation of heparin-like sulfated polysaccharides with potent anti-SARS-CoV-2 activity from snail mucus of Achatina fulica
por: Kodchakorn, Kanchanok, et al.
Publicado: (2023)

Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents
por: Asrorov, Akmal M., et al.
Publicado: (2022)

Accurate construction of cell membrane biomimetic graphene nanodecoys via purposeful surface engineering to improve screening efficiency of active components of traditional Chinese medicine
por: Hu, Qi, et al.
Publicado: (2022)

Neutrophil membrane-mimicking nanodecoys with intrinsic anti-inflammatory properties alleviate sepsis-induced acute liver injury and lethality in a mouse endotoxemia model
por: Xiao, Yao, et al.
Publicado: (2022)

Nebulized Heparin in Burn Patients with Inhalation Trauma—Safety and Feasibility
por: Glas, Gerie J., et al.
Publicado: (2020)

Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants
por: Gelbach, Adrianne L., et al.
Publicado: (2022)

Heparin and SARS-CoV-2: Multiple Pathophysiological Links
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron
por: Zhang, Li, et al.
Publicado: (2021)

Copper-Heparin Inhalation Therapy To Repair Emphysema: A Scientific Rationale
por: Janssen, Rob, et al.
Publicado: (2019)

In silico investigations of heparin binding to SARS‐CoV‐2 variants with a focus at the RBD/ACE2 interface
por: Ali, Nemat, et al.
Publicado: (2022)

Nonclinical Evaluation of Novel Cationically Modified Polysaccharide Antidotes for Unfractionated Heparin
por: Kalaska, Bartlomiej, et al.
Publicado: (2015)

Extension of the SUGRES-1P Coarse-Grained Model of Polysaccharides to Heparin
por: Danielsson, Annemarie, et al.
Publicado: (2023)

Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy
por: Minenkova, Olga, et al.
Publicado: (2022)

Inhalable nanocatchers for SARS-CoV-2 inhibition
por: Zhang, Han, et al.
Publicado: (2021)

Clinical characteristics of liver injury in SARS-CoV-2 Omicron variant- and Omicron subvariant-infected patients
por: Deng, Haohui, et al.
Publicado: (2023)

Impact of nebulized unfractionated heparin and N-acetylcysteine in management of smoke inhalation injury
por: Elamin, E, et al.
Publicado: (2009)

Nebulized heparin and N-acetylcysteine for smoke inhalational injury: A case report
por: Ashraf, Umair, et al.
Publicado: (2018)

Inhalational injury and use of heparin & N-acetylcysteine nebulization: A case report
por: Shaikh, Nissar, et al.
Publicado: (2022)

An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV‐2
por: Zhang, Lianghui, et al.
Publicado: (2022)

Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives
por: Tandon, Ritesh, et al.
Publicado: (2020)

The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom
por: Wu, Jiajing, et al.
Publicado: (2021)

Heparin nebulization attenuates acute lung injury with sepsis after smoke inhalation in sheep
por: Murakami, K, et al.
Publicado: (2001)

Nebulized heparin for inhalation injury in burn patients: a systematic review and meta-analysis
por: Lan, Xiaodong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_77udv2q2u573eup4le7003hc4m